JE00BYSS4X48
JE00BYSS4X48
NovoCure Limited
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 655.353.000 | 605.220.000 | 8.3% |
| Cost of Revenue | 166.879.000 | 137.181.000 | 21.6% |
| Gross Profit | 488.474.000 | 468.039.000 | 4.4% |
| 642.274.000 | 638.535.000 | 0.6% | |
| Operating Income | -153.800.000 | -170.496.000 | 9.8% |
| Pretax Income | -136.250.000 | -131.162.000 | 3.9% |
| Net Income Common Stockholders | -136.227.000 | -168.627.000 | 19.2% |
| -- | -- | -- | |
| -- | -- | -- |